DOLE-EUROPE
2.2.2015 12:02:02 CET | Business Wire | Pressemeddelelse
With "Dole Earth", Dole has set new marketing standards in recent years that go far beyond the quality and taste of its products. Building on that success, Dole Europe is launching “My Energy” in 2015, an innovative campaign keyed to the theme of energy and promoting a healthy, high-energy lifestyle among consumers. The campaign will be featured on Dole’s stand at Fruit Logistica which will revolve around the theme of energy.
Dole Foods is owned and headed by the visionary, entrepreneur David Murdock who was driven by a passion to research and communicate the health benefits of fruit and vegetables when he established the North Carolina Research Campus (NCRC) in 2005. Today some 300 scientists from 8 top research universities are engaged in projects focusing on human health, nutrition and agriculture there. Dole also researches on the campus under its own name through the Dole Nutrition Institute. Dole scientists are conducting research projects to show how the nutrients in fruit and vegetables influence people's health, capabilities and aging processes. Murdock is taking their conclusions to heart himself. His formula for a long and fulfilling life: eat healthily, exercise regularly and pursue a goal in life. The trade fair stand will feature a film that perfectly captures Murdock's vision and presents them in the context of his research initiatives and philosophy. And the energy theme is sustained throughout the stand, e.g. with a smoothie bar where visitors can replenish their energy levels and a "Top up on Energy" station where they can recharge the batteries in their mobile devices.
The campaign will begin with a promotion for consumers in the second quarter of 2015. “My Energy” will communicate the results of the research projects conducted at NCRC and the benefits of an energy-filled and rewarding lifestyle.
Visit Dole Europe at the Fruit Logistica and meet fruit experts from around the globe . You will find Dole from February 4-6 at Stand A-02 in Hall 6.2 (South Entrance).
Dole Europe is the European division of Dole Foods, one of the world’s largest suppliers of fresh fruit and vegetables. Dole Europe imports a wide range of fresh fruit and vegetables from both Dole Food Company’s own farms and independent growers all over the world. Dole Europe also provides retailers with innovative solutions for services and products. Its network stretches from Scandinavia to South Africa, from Italy to Russia and the Middle East. More information at www.dole.eu .
Contact:
Dole Europe GmbH
Xavier Roussel, Stadtdeich 7, 20097 Hamburg,
Germany
xavier.roussel@dole.com
,
Tel.:+49 40 32906-0
or
segmenta communications
Kristin
Schuh, Feldbrunnenstraße 52, 20148 Hamburg, Germany
schuh@segmenta.de
,
Tel.: +49 40 44 11 30-44
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Alipay Launches Next-Generation AI Payment Infrastructure, Debuts AI Wallet and Token Pay to Power Agentic Economy26.5.2026 17:20:00 CEST | Press release
Alipay today introduced its full-stack AI payment solution to partners across industries, ranging from AI companies to traditional retailers, and debuted two new services — the world’s first AI Wallet and Token Pay — to support the agentic economy’s rapid growth. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526337824/en/ Alipay Unveils Next-generation AI Payment Infrastructure This launch extends Alipay's next-generation AI payment infrastructure, building on its consumer-facing product Alipay AI Pay and its business-facing AI payment processing product. “While the essence of commerce remains unchanged in the age of AI, the emergence of AI agents is reshaping everything. Drawing on 22 years of technological expertise and commercial know-how, Alipay is building a new generation of AI payment services to accelerate the growth of the agentic commerce ecosystem,” said Cyril Han, CEO of Ant Group. AI Wallet: Giving Users Vis
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 202626.5.2026 17:00:00 CEST | Press release
Presentations at the 94th European Atherosclerosis Society (EAS) Congress highlight the breadth of evidence for bempedoic acid across a wide range of patient subgroups and background therapies. Real-world data from the MILOS study across multiple European cohorts demonstrate consistent effectiveness and safety profile in routine clinical practice.1,2,3,4 Analysis from the CLEAR Outcomes trial underscores the impact of bempedoic acid on cardiovascular risks, including stroke and venous thromboembolism (VTE).5,6 Daiichi Sankyo Europe’s commitment to "care for every heartbeat" is centred on providing accessible oral treatment options to ensure every patient is given a chance to reach their LDL-C goals. Daiichi Sankyo Europe (DSE) is pleased to announce its extensive scientific presence at the European Atherosclerosis Society (EAS) Congress 2026. The presentation of 15 abstracts, comprising both clinical trial analyses and real-world evidence, underscores the company's sustained investment
OpenRouter Raises $113 Million CapitalG-led Series B as Weekly Volume Explodes to 25T Tokens26.5.2026 15:15:00 CEST | Press release
NVentures, ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures join CapitalG, a16z, Menlo Ventures, and others in backing the high-growth AI infrastructure startup OpenRouter, the AI model exchange, today announced a $113 million Series B led by Alphabet’s independent growth fund, CapitalG, with participation from investors including NVentures (NVIDIA’s venture capital arm), ServiceNow Ventures, MongoDB Ventures, Snowflake Ventures, Databricks Ventures, alongside existing investors including Andreessen Horowitz and Menlo Ventures. OpenRouter’s volume has surged to 25 trillion tokens per week (100 trillion tokens per month), representing a 5X increase from the 5 trillion tokens processed per week just six months ago. The explosion in token demand illustrates how quickly enterprises are deploying agents and scaling AI across multiple models and providers. OpenRouter’s infrastructure manages and optimizes inference and provides access to 400+ models across leadi
Xsolla Expands Its Community Management Tools for Creators, Community Leaders, and Resellers26.5.2026 15:00:00 CEST | Press release
Xsolla Adds New Features For Creators, Community Leader Experience, And Distinct Channels For Emerging Markets Xsolla, a leading global video game commerce company, today announced three simultaneous expansions of its community management tools and products. As the creator economy continues to reshape how games are discovered and the industry accelerates its shift toward direct-to-consumer commerce, Xsolla is building on its community management tools for creators, community leaders, and emerging markets, and will showcase them at TwitchCon Rotterdam later this month. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260526596720/en/ Graphic: Xsolla The games industry has never had a shortage of people who drive player acquisition, loyalty, and commerce; it's had a shortage of infrastructure that recognizes them. Creators stream it. Community leaders build a culture around it. Local resellers get it into the hands of players in
Biocytogen Launches AI-Powered RenSuper™ Platform and Industry-First Fully Automated Antibody Discovery Infrastructure26.5.2026 14:00:00 CEST | Press release
Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® platforms, RenSuper establishes a closed-loop antibody discovery engine combining in vivo immune repertoires, AI-driven candidate selection, automated experimental validation, and scalable manufacturing infrastructure. The platform supports the discovery and development of monoclonal antibodies, bispecifics, multispecifics, antibody-drug conjugates (ADCs), VHHs, and other advanced therapeutic modalities, significantly reducing the time and risk associated with antibody discovery. RenSuper Workstation: AI-Powered One-Click Tar
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum
